Beta Bionics, Inc. Common Stock (BBNX) Ownership

$30.00

$0.4 (-1.32%)
Last update: 04:00 PM EST
Day's range
$29.56
Day's range
$31.51

Beta Bionics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
EVENTIDE ASSET MANAGEMENT, LLC 11/14/2025 4.96 M $98.50 M   0.50% 11.42%
FARALLON CAPITAL MANAGEMENT LLC 11/14/2025 4.31 M $85.72 M   2.62% 9.94%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 3.90 M $77.52 M   0.00% 8.99%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2025 3.87 M $76.90 M   1.31% 8.92%
MORGAN STANLEY 11/14/2025 3.76 M $74.74 M   27.54% 8.67%
SANDS CAPITAL VENTURES, LLC 11/13/2025 3.57 M $70.94 M   0.00% 8.23%
RTW INVESTMENTS, LP 11/14/2025 3.30 M $65.55 M   0.00% 7.60%
BLACKROCK, INC. 11/12/2025 2.78 M $55.27 M   224.03% 6.41%
VANGUARD GROUP INC 11/07/2025 2.22 M $44.04 M   213.48% 5.11%
OMEGA FUND MANAGEMENT, LLC 11/14/2025 1.92 M $38.15 M   -3.43% 4.43%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2025 1.17 M $23.22 M   0.00% 2.69%
DRIEHAUS CAPITAL MANAGEMENT LLC 11/14/2025 1.06 M $21.04 M   -8.69% 2.44%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 917.55 K $18.24 M   193.21% 2.11%
STATE STREET CORP 11/14/2025 826.30 K $16.42 M   259.27% 1.90%
MILLENNIUM MANAGEMENT LLC 11/14/2025 796.96 K $15.84 M   46.99% 1.84%
JANUS HENDERSON GROUP PLC 11/14/2025 650.83 K $12.93 M   -2.23% 1.50%
VESTAL POINT CAPITAL, LP 11/14/2025 600.00 K $11.92 M   9.09% 1.38%
MARSHALL WACE, LLP 11/13/2025 594.90 K $11.82 M   -3.26% 1.37%
WALLEYE CAPITAL LLC 11/14/2025 591.19 K $11.75 M   170.95% 1.36%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 487.66 K $9.69 M   53.38% 1.12%
GOLDMAN SACHS GROUP INC 11/14/2025 399.25 K $7.93 M   28.38% 0.92%
LORD, ABBETT & CO. LLC 11/13/2025 364.45 K $7.24 M   -13.10% 0.84%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 330.69 K $6.57 M   223.49% 0.76%
NORTHERN TRUST CORP 11/14/2025 298.06 K $5.92 M   212.91% 0.69%
PURA VIDA INVESTMENTS, LLC 11/12/2025 281.25 K $5.59 M   11,150.00% 0.65%
PERCEPTIVE ADVISORS LLC 11/14/2025 277.94 K $5.52 M   -82.56% 0.64%
FIRST EAGLE INVESTMENT MANAGEMENT, LLC 11/12/2025 233.20 K $4.63 M   100.00% 0.54%
ESSEX INVESTMENT MANAGEMENT CO LLC 11/06/2025 222.62 K $4.42 M   100.00% 0.51%
JPMORGAN CHASE & CO 11/26/2025 205.96 K $4.09 M   3,238.01% 0.47%
RAYMOND JAMES FINANCIAL INC 11/14/2025 204.29 K $4.06 M   -5.57% 0.47%
BANK OF AMERICA CORP /DE/ 11/14/2025 197.71 K $3.93 M   173.66% 0.46%
CLEARBRIDGE INVESTMENTS, LLC 11/13/2025 197.05 K $3.92 M   -21.10% 0.45%
SCHONFELD STRATEGIC ADVISORS LLC 11/14/2025 183.66 K $3.65 M   161.72% 0.42%
TWO SIGMA INVESTMENTS, LP 11/14/2025 163.76 K $3.25 M   668.99% 0.38%
GILDER GAGNON HOWE & CO LLC 11/14/2025 162.65 K $3.23 M   -33.40% 0.37%
UBS GROUP AG 11/13/2025 127.91 K $2.54 M   33.15% 0.29%
LONGAEVA PARTNERS L.P. 11/14/2025 125.48 K $2.49 M   -36.18% 0.29%
KENT LAKE PR LLC 11/14/2025 125.00 K $2.48 M   100.00% 0.29%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 11/14/2025 114.67 K $2.28 M   28.69% 0.26%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 94.23 K $1.87 M   11,461.60% 0.22%
BANK OF NEW YORK MELLON CORP 11/03/2025 90.12 K $1.79 M   229.46% 0.21%
GRANAHAN INVESTMENT MANAGEMENT, LLC 11/14/2025 85.74 K $1.70 M   100.00% 0.20%
ROYAL BANK OF CANADA 11/14/2025 75.78 K $1.51 M   2,818.91% 0.17%
MERIDIEM CAPITAL PARTNERS LP 11/13/2025 73.39 K $1.46 M   100.00% 0.17%
BELLEVUE GROUP AG 11/14/2025 64.28 K $1.28 M   -3.80% 0.15%
LEGATO CAPITAL MANAGEMENT LLC 11/12/2025 63.63 K $1.26 M   100.00% 0.15%
TD ASSET MANAGEMENT INC 11/10/2025 60.08 K $1.19 M   50.66% 0.14%
DARK FOREST CAPITAL MANAGEMENT LP 11/17/2025 56.26 K $1.12 M   100.00% 0.13%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2025 55.27 K $1.10 M   640.83% 0.13%
BARCLAYS PLC 11/12/2025 54.41 K $1.08 M   139.92% 0.13%

Beta Bionics, Inc. institutional Ownership - FAQ's

During the previous two years, 144 institutional investors and hedge funds held shares of Beta Bionics, Inc.. The most heavily invested institutionals were:

EVENTIDE ASSET MANAGEMENT, LLC: 4.96 M

FARALLON CAPITAL MANAGEMENT LLC: 4.31 M

WELLINGTON MANAGEMENT GROUP LLP: 3.9 M

Soleus Capital Management, L.P.: 3.87 M

MORGAN STANLEY: 3.76 M

Sands Capital Ventures, LLC: 3.57 M

111.42% of Beta Bionics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 48.35 M shares in the last 24 months. This purchase volume represents approximately $1.45 B in transactions.